| Derechos | Preview | Fecha Public. | Título | Autor(es) | Tipo |
| openAccess |  | 30-ago-2019 | Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer | Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Burgos, Miguel; Gómez-Juárez, Mónica; Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Alberto | artículo |
| openAccess |  | 2022 | Antitumoral activity of a CDK9 PROTAC compound in HER2-Positive breast cancer | Noblejas-López, María del Mar; Gandullo-Sánchez, Lucía CSIC ORCID; Galán-Moya, Eva María; López-Rosa, Raquel; Tebar-García, David; Nieto-Jiménez, Cristina; Gómez-Juárez, Mónica; Burgos, Miguel; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 2021 | Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer | Nieto-Jiménez, Cristina; Alcaraz-Sanabria, Ana; Martínez-Canales, Sandra; Corrales-Sánchez, Verónica; Montero, Juan Carlos CSIC ORCID; Burgos, Miguel; Nuncia-Cantarero, Miriam; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Alberto | artículo |
| openAccess |  | 12-nov-2020 | Crocetin isolated from the natural food colorant saffron reduces intracellular fat in 3T3-L1 adipocytes | Jiménez-Ortega, Elena CSIC ORCID; Braza-Boils, Aitana; Burgos, Miguel; Moratalla-López, Natalia; Vicente, Manuel; Alonso, Gonzalo L.; Nava, Eduardo; Llorens, Silvia | artículo |
| openAccess |  | 6-jul-2017 | Enhanced vulnerability of human proteins towards disease-associated inactivation through divergent evolution | Medina-Carmona, Encarnación; Fuchs, Julian E.; Gavira Gallardo, J. A. CSIC ORCID ; Mesa Torres, Noel CSIC ORCID; Neira, José L. CSIC ORCID; Salido, Eduardo; Palomino-Morales, Rogelio; Burgos, Miguel; Timson, David; Pey, Ángel L. | artículo |
| openAccess |  | 2020 | Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancer | Nieto-Jiménez, Cristina; Galán-Moya, Eva María; Corrales-Sánchez, Verónica; Noblejas-López, María del Mar; Burgos, Miguel; Domingo, Beatriz; Montero, Juan Carlos CSIC ORCID; Gómez-Juárez, Mónica; Picazo-Martinez, Maria Granada; Esparís-Ogando, Azucena CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 2021 | MZ1 co-operates with trastuzumab in HER2 positive breast cancer | Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Galán-Moya, Eva María; Tebar-García, David; Pandiella, Atanasio CSIC ORCID CVN ; Burgos, Miguel; Ocaña, Alberto | artículo |
| openAccess |  | may-2012 | Pattern and density of vascularization in mammalian testes, ovaries, and ovotestes | Lupiáñez, Darío G; Real, Francisca M; Dadhich, Rajesh K; Carmona, Francisco D; Burgos, Miguel; Barrionuevo, Francisco J; Jiménez, Rafael | artículo |
| openAccess |  | 2020 | Pharmacological screening and transcriptomic functional analyses identify a synergistic interaction between dasatinib and olaparib in triple‐negative breast cancer | Corrales-Sánchez, Verónica; Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Pérez-Peña, Javier; Montero, Juan Carlos CSIC ORCID; Burgos, Miguel; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 19-ene-2022 | Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis | Burgos, Miguel; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Alberto | artículo |
| openAccess | | 21-ene-2022 | sj-docx-1-tam-10.1177_17588359211072621 – Supplemental material for Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis [Dataset] | Burgos, Miguel; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Alberto | dataset |
| openAccess | | 21-ene-2022 | sj-docx-2-tam-10.1177_17588359211072621 – Supplemental material for Prognostic value of the immune target CEACAM6 in cancer a meta-analysis [Dataset] | Burgos, Miguel; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Alberto | dataset |
| openAccess |  | 21-ene-2022 | sj-jpg-1-tam-10.1177_17588359211072621 – Supplemental material for Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis [Dataset] | Burgos, Miguel; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Alberto | dataset |
| openAccess |  | 21-ene-2022 | sj-jpg-2-tam-10.1177_17588359211072621 – Supplemental material for Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis [Dataset] | Burgos, Miguel; Cavero-Redondo, Iván; Álvarez-Bueno, Celia; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Amir, Eitan; Ocaña, Alberto | dataset |
| openAccess |  | 15-nov-2009 | SOX9 is not required for the cellular events of testicular organogenesis in XX mole ovotestes | Carmona, F David; Lupiáñez, Darío G; Real, Francisca M; Burgos, Miguel; Zurita, Federico; Jiménez, Rafael | artículo |
| openAccess |  | 2017 | Synthetic lethality interaction between aurora kinases and CHEK1 inhibitors in ovarian cancer | Alcaraz-Sanabria, Ana; Nieto-Jiménez, Cristina; Corrales-Sánchez, Verónica; Serrano-Oviedo, Leticia; Andrés-Pretel, Fernando; Montero, Juan Carlos CSIC ORCID; Burgos, Miguel; Llopis, Juan; Galán-Moya, Eva María; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 2017 | Targeting basal-like breast tumors with bromodomain and extraterminal domain (BET) and polo-like kinase inhibitors | Nieto-Jiménez, Cristina; Alcaraz-Sanabria, Ana; Pérez-Peña, Javier; Corrales-Sánchez, Verónica; Serrano-Heras, Gemma CSIC ORCID; Galán-Moya, Eva María; Serrano-Oviedo, Leticia; Montero, Juan Carlos CSIC ORCID; Burgos, Miguel; Llopis, Juan; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
